Jones Financial Companies Lllp Grows Position in Healthpeak Properties, Inc. (NYSE:DOC)

Jones Financial Companies Lllp lifted its position in Healthpeak Properties, Inc. (NYSE:DOC) by 21.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 11,963 shares of the real estate investment trust’s stock after buying an additional 2,118 shares during the quarter. Jones Financial Companies Lllp’s holdings in Healthpeak Properties were worth $242,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Avior Wealth Management LLC bought a new position in Healthpeak Properties during the third quarter valued at approximately $37,000. Groupama Asset Managment bought a new position in Healthpeak Properties in the 3rd quarter worth about $37,000. Wiser Advisor Group LLC bought a new position in Healthpeak Properties in the 3rd quarter worth about $42,000. Continuum Advisory LLC purchased a new position in Healthpeak Properties in the 3rd quarter worth about $44,000. Finally, AdvisorNet Financial Inc raised its position in Healthpeak Properties by 34.5% in the 4th quarter. AdvisorNet Financial Inc now owns 2,193 shares of the real estate investment trust’s stock worth $44,000 after buying an additional 563 shares during the last quarter. 93.57% of the stock is owned by hedge funds and other institutional investors.

Healthpeak Properties Trading Down 0.6 %

Healthpeak Properties stock opened at $20.21 on Thursday. The stock has a 50-day moving average price of $20.21 and a 200 day moving average price of $21.26. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 0.96. The company has a market capitalization of $14.13 billion, a price-to-earnings ratio of 57.73, a price-to-earnings-growth ratio of 2.17 and a beta of 1.14. Healthpeak Properties, Inc. has a 52 week low of $16.66 and a 52 week high of $23.26.

Healthpeak Properties Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, February 26th. Stockholders of record on Friday, February 14th were given a $0.305 dividend. The ex-dividend date was Friday, February 14th. This is a boost from Healthpeak Properties’s previous quarterly dividend of $0.30. This represents a $1.22 dividend on an annualized basis and a dividend yield of 6.04%. Healthpeak Properties’s payout ratio is 348.57%.

Analysts Set New Price Targets

Several equities research analysts have recently commented on DOC shares. Morgan Stanley raised shares of Healthpeak Properties from an “equal weight” rating to an “overweight” rating and set a $25.00 price target for the company in a research report on Wednesday, January 15th. Mizuho decreased their price target on Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating on the stock in a report on Thursday, December 5th. Scotiabank reduced their target price on Healthpeak Properties from $24.00 to $23.00 and set a “sector outperform” rating on the stock in a research note on Friday, February 28th. Wedbush cut their price target on Healthpeak Properties from $27.00 to $24.00 and set an “outperform” rating on the stock in a research note on Friday, February 14th. Finally, Wells Fargo & Company dropped their price objective on Healthpeak Properties from $23.00 to $22.00 and set an “equal weight” rating on the stock in a research report on Tuesday, December 10th. One analyst has rated the stock with a sell rating, three have issued a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $23.92.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.